The outcome of neurology outpatients with medically unexplained symptoms: A prospective cohort study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 7, 2003, Pages 897-900

  Carson, A J ^a   Best, S ^b   Postma, K ^b   Stone, J ^b   Warlow, C ^b   Sharpe, M ^b  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; RATING SCALE; SYMPTOMATOLOGY;

EID: 0037967243     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.7.897     Document Type: Article

References (33)

1. Carson AJ, Ringbauer B, Stone J, et al. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry 2000;68:207-10.
2. Crimlisk HL, Bhatia K, Cope H, et al. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 1998;316:582-6.
3. Couprie W, Wijdicks E-FM, Rooijmans H-GM, et al. Outcome in conversion disorder: a follow up study. J Neurol Neurosurg Psychiatry 1995;58:750-2.
4. Binzer M, Kullgren G. Motor conversion disorder. A prospective 2- to 5-year follow-up study. Psychosomatics 1998;39:519-27.
5. Meierkord H, Will B, Fish D, et al. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology 1991;41:1643-6.
6. Ettinger AB, Dhoon A, Weisbrot DM, et al. Predictive factors for outcome of nonepileptic seizures after diagnosis. J Neuropsychiatry Clin Neurosci 1999;11:458-63.
7. Kanner AM, Parra J, Frey M, et al. Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome. Neurology 1999;53:933-8.
8. Gatfield PD, Guze SB. Prognosis and differential diagnosis of conversion reactions. Dis Nerv Sys 1962;23:623-31.
9. Stefansson JG, Messina JA, Meyerowitz S. Hysterical neurosis, conversion type: clinical and epidemiological considerations. Acta Psychiatr Scand 1976;53:119-38.
10. Lewis A. The survival of hysteria. In: Roy A, ed. Hysteria. Chichester: John Wiley and Sons, 1982:21-6.
11. Reed JL. The diagnosis of "hysteria." Psychol Med 1975;5:13-17.
12. Wig NN, Mangalwedhe K, Bedi H, et al. A follow-up study of hysteria. Ind J Psychiatry 1982;24:120-5.
13. Ponnudurai R, Somasundaram O, Balakrishnan S, et al. Hysteria - a psychodemographic study. Ind J Psychiatry 1981;23:49-51.
14. Subramanian D, Subramanian K, Devaky MN, et al. A clinical study of 276 patients diagnosed as suffering from hysteria. Ind J Psychiatry 1980;22:63-8.
15. Hafeiz HB. Hysterical conversion: a prognostic study. Br J Psychiatry 1980;136:548-51.
16. Krull F, Schifferdecker M. Inpatient treatment of conversion disorder: a clinical investigation of outcome. Psychother Psychosom 1990;53:161-5.
17. Chandrasekaran R, Goswami U, Sivakumar V, et al. Hysterical neurosis - a follow-up study. Acta Psychiatr Scand 1994;89:78-80.
18. Kent DA, Tomasson K, Coryell W. Course and outcome of conversion and somatization disorders. A four-year follow-up. Psychosomatics 1995;36:138-44.
19. Mace CJ, Trimble MR. Ten-year prognosis of conversion disorder. Br J Psychiatry 1996;169:282-8.
20. Jacobs H, Russell WR. Functional disorders. A follow up study. BMJ 1961;ii:346-9.
21. Slater ET. Diagnosis of "hysteria." BMJ 1965;i:1395-9.
22. Speckens AE, Van Hemert AM, Bolk JH, et al. Unexplained physical symptoms: outcome, utilization of medical care and associated factors. Psychol Med 1996;26:745-52.
23. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health survey manual and interpretation guide. Boston: The Health Institute, 1993.
24. Spitzer RL, Williams JB, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994;272:1749-56.
25. American Psychiatric Association. Diagnostic and statistical manual of diseases. Washington DC: American Psychiatric Association, 1994.
26. Guy W. Early clinical drug evaluation (ECDEU) assessment manual. Rockville: National Institute for Mental Health, 1976.
27. Wells KB, Burnam MA, Leake B, et al. Agreement between face-to-face and telephone-administered versions of the depression section of the NIMH Diagnostic Interview Schedule. J Psychiatr Res 1988;22:207-20.
28. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: how often and why are they missed? Q J Med 2000;93:21-8.
29. Hankey GJ, Stewart-Wynne EG. Pseudo-multiple sclerosis: a clinico-epidemiological study. Clin Exp Neurol 1987;24:11-19.
30. Gureje O, Simon GE, Ustun TB, et al. Somatization in cross-cultural perspective: a World Health Organisation study in primary care. Am J Psychiatr 1997;154:989-95.
31. Smith GR, Monson RA, Ray DC. Psychiatric consultation in somatization disorder. A randomized controlled study. N Engl J Med 1986;314:1407-13.
32. O'Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48:980-90.
33. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 2000;69:205-15.